CJ - a slide from the BIO 2/14 conference shows NSCLC 1st Line Topline ORR to be released "1Q12" fyi....so within the next month. Slide shown at the very bottom of your post:
When they set up the trial protocol they establish a criteria for significance and results are not released until that significance has been established. It's typically based on the O'Brien-Fleming stopping boundaries.
For the phase 2 signal seeking trials, IMO, significance was established when 80% of the patients had expired and at that point they released the MOS numbers.
Market Data 
Markets 
